N/A
N=40
Multi-component Workplace Energy Balance Intervention
Abdominal Obesity
Bottom Line
View on ClinicalTrials.gov: NCT02561611 ↗Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Change in Visceral Adipose Tissue (VAT), Measured in kg — .04; -0.10 kg
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Intervention Group (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Pennington Biomedical Research Center
- Primary completion
- May 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Visceral Adipose Tissue (VAT), Measured in kg |
.04; -0.10 | — |
| SECONDARY Changes in Body Weight |
-0.3; -0.9 | — |
Summary
The purpose of the WorkACTIVE-P study is to assess the outcome of an innovative multi-component intervention focused on increasing energy expenditure and re-balancing the disrupted energy balance equation of sedentary workplaces with an ultimate target of reducing workers' abdominal obesity.
Eligibility Criteria
Inclusion Criteria
- BMI: > or equal to 25.0 kg/m2 and 102 cm (men) or > 88 cm (women)
- Any one of the other four defining risk factors defining metabolic syndrome (Triglycerides > or equal to 150 mg/dL , HDL Cholesterol or equal to 130 mm Hg systolic / 85 mm Hg diastolic, Fasting glucose > or equal to 110 mg/dL)
Exclusion Criteria
- Systolic blood pressure > 179 mmHg and/or diastolic blood pressure > 99 mmHg
- Self-reported Type 1 or Type 2 diabetes, or use of diabetes-related medications
- Significant CVD or disorders
- Other significant medical conditions including but not limited to implants that may interfere with MRI, chronic respiratory, gastrointestinal, neuromuscular, or psychiatric conditions, malignancies in the past 5 years, with the exception of skin cancer therapeutically controlled, endocrine (including diabetes), any other medical conditions or disease (including arthritis) that is life threatening or that can interfere with or be aggravated by exercise.
- Poor compliance to activity monitors
Data sourced from ClinicalTrials.gov (NCT02561611). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.